Methods for use in modulating miR-122a

Details for Australian Patent Application No. 2011254085 (hide)

Owner Regulus Therapeutics Inc.

Inventors Bhanot, Sanjay; Esau, Christine

Agent Spruson & Ferguson

Pub. Number AU-B-2011254085

Parent 2006284855

Filing date 15 December 2011

Wipo publication date 19 January 2012

Acceptance publication date 1 November 2012

International Classifications

A61K 31/711 - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

12 January 2012 Complete Application Filed

19 January 2012 Application Open to Public Inspection

  Published as AU-B-2011254085

1 November 2012 Application Accepted

  Published as AU-B-2011254085

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011254086-Process cartridge and image forming apparatus

2011254084-Developing apparatus, process cartridge and electrophotographic image forming apparatus